These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9301284)

  • 1. [Possible involvement of donor-derived B cells in development of post-transfusion graft-versus-host disease].
    Nishimura M; Akaza T; Tadokoro K; Juji T
    Nihon Rinsho; 1997 Sep; 55(9):2246-51. PubMed ID: 9301284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of involvement of cytotoxic antibodies directed against patients's HLA class II produced by transfused donor-derived B cells in post-transfusion graft-versus-host disease.
    Nishimura M; Uchida S; Mitsunaga S; Tokunaga K; Tadokoro K; Juji T
    Br J Haematol; 1996 Mar; 92(4):1011-3. PubMed ID: 8616060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Remarkable increase of CD8+ CD11a+ and CD8+ CD57- T cells in patients with post-transfusion graft-versus-host disease].
    Karasuno T; Nakamura H; Fukuda H; Okajima Y; Maeda T; Teshima H; Hiraoka A; Masaoka T
    Rinsho Ketsueki; 1998 Sep; 39(9):716-8. PubMed ID: 9796409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)].
    Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F
    Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor.
    Ryo R; Saigo K; Hashimoto M; Kohsaki M; Yasufuku M; Watanabe N; Okada M; Tadokoro K; Juji T
    Vox Sang; 1999; 76(4):241-6. PubMed ID: 10394145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted use of T-cell receptor V beta genes in posttransfusion graft-versus-host disease.
    Wang L; Tadokoro K; Tokunaga K; Uchida S; Moriyama S; Bannai M; Mitsunaga S; Takai K; Juji T
    Transfusion; 1997; 37(11-12):1184-91. PubMed ID: 9426644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of transfusion-associated graft-versus-host disease.
    Yasuda H; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):69-75. PubMed ID: 7927137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis.
    Sage D; Stanworth S; Turner D; Navarrete C
    Transfus Med; 2005 Dec; 15(6):481-5. PubMed ID: 16359419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of transfusion-associated graft-versus-host disease].
    Yasukawa M
    Nihon Rinsho; 1997 Sep; 55(9):2290-5. PubMed ID: 9301292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.
    Delbos F; Barhoumi W; Cabanne L; Beckerich F; Robin C; Redjoul R; Astati S; Toma A; Pautas C; Ansart-Pirenne H; Cordonnier C; Bierling P; Maury S
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):292-299. PubMed ID: 26453972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular diagnosis of post-transfusion GVHD using Y-chromosome specific sequences].
    Hayakawa S; Satoh K
    Nihon Rinsho; 1997 Sep; 55(9):2272-6. PubMed ID: 9301289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transfusion-associated graft-versus-host disease].
    Bojanić I; Cepulić BG
    Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic diagnosis for post-transfusion graft-versus-host disease using PCR amplification of variable number of tandem repeats].
    Uchida S; Yahagi H
    Nihon Rinsho; 1997 Sep; 55(9):2267-71. PubMed ID: 9301288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.
    Gilstad C; Roschewski M; Wells J; Delmas A; Lackey J; Uribe P; Popa C; Jardeleza T; Roop S
    Transfusion; 2012 May; 52(5):930-5. PubMed ID: 21981662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistological study of post-transfusion graft-versus-host disease (GVHD).
    Hojo H; Kainuma Y; Kunori T; Wachi E; Wakasa H
    Fukushima J Med Sci; 1993 Dec; 39(2):77-87. PubMed ID: 7927138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of post-transfusion graft-versus-host disease after formalin-fixation.
    Ryo R; Goto M; Takada M; Saigo K; Yamaguchi N; Hayashi M; Ito H; Onoyama H; Saito Y; Uchida S
    Int J Hematol; 1994 Jun; 59(4):297-302. PubMed ID: 8086623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD].
    Takahashi K
    Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of post transfusion graft-versus-host disease.
    Juji T; Nishimura M; Tadokoro K
    Vox Sang; 2000; 78 Suppl 2():277-9. PubMed ID: 10938969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.